V M Rivera

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery
    V M Rivera
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Brain Inj 19:725-7. 2005
  2. ncbi [Deciding on treatment in multiple sclerosis]
    V M Rivera
    Department of Neurology Baylor College of Medicine 6560 Fannin, Suite 1224, Houston, Texas, 77030, USA
    Rev Neurol 36:80-5. 2003
  3. ncbi [Pharmacologic treatment of multiple sclerosis]
    V M Rivera
    Department of Neurology, Baylor College of Medicine, 6560 Fannin, Suite 1224, Houston, Texas 77030, USA
    Rev Neurol 32:285-8. 2001
  4. ncbi [Neuroimaging in multiple sclerosis]
    V M Rivera
    Department of Neurology, Baylor College of Medicine, 6560 Fannin, Suite 1224, Houston, Texas 77030, USA
    Rev Neurol 32:283-5. 2001
  5. ncbi [The treatment of multiple sclerosis with beta-interferon 1a]
    V M Rivera
    Dpto de NeurologĂ­a, Baylor College of Medicine, Houston, Texas 77030, USA
    Rev Neurol 31:470-1. 2000
  6. ncbi Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
    Y C Zang
    Department of Neurology, Baylor College of Medicine, and Baylor Methodist Multiple Sclerosis Center, Houston 77030, USA
    Eur J Immunol 29:1692-700. 1999
  7. ncbi Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis
    Y C Zang
    Multiple Sclerosis Research Laboratory, Department of Neurology, Baylor College of Medicine, Houston 77030, USA
    Eur J Immunol 30:908-13. 2000
  8. ncbi Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals
    M V Tejada-Simon
    Multiple Sclerosis Research Laboratory, Baylor-Methodist Multiple Sclerosis Center and Department of Neurology, Baylor College of Medicine, Houston, USA
    Eur J Immunol 31:907-17. 2001
  9. ncbi Urodynamic pattern changes in multiple sclerosis
    S J Ciancio
    Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA
    Urology 57:239-45. 2001
  10. ncbi Anti-viral properties of interferon beta treatment in patients with multiple sclerosis
    J Hong
    Department of Neurology and Baylor Methodist Multiple Sclerosis Center, Houston, Texas, USA
    Mult Scler 8:237-42. 2002

Collaborators

Detail Information

Publications12

  1. ncbi Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery
    V M Rivera
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Brain Inj 19:725-7. 2005
    ....
  2. ncbi [Deciding on treatment in multiple sclerosis]
    V M Rivera
    Department of Neurology Baylor College of Medicine 6560 Fannin, Suite 1224, Houston, Texas, 77030, USA
    Rev Neurol 36:80-5. 2003
    ....
  3. ncbi [Pharmacologic treatment of multiple sclerosis]
    V M Rivera
    Department of Neurology, Baylor College of Medicine, 6560 Fannin, Suite 1224, Houston, Texas 77030, USA
    Rev Neurol 32:285-8. 2001
    ..Multiple sclerosis (MS) is probably caused by many pathological factors, both intrinsic and extrinsic...
  4. ncbi [Neuroimaging in multiple sclerosis]
    V M Rivera
    Department of Neurology, Baylor College of Medicine, 6560 Fannin, Suite 1224, Houston, Texas 77030, USA
    Rev Neurol 32:283-5. 2001
    ..Multiple sclerosis is currently considered to be a destructive disorder, and a certain degree of alteration in immunity is considered to occur in genetically susceptible persons...
  5. ncbi [The treatment of multiple sclerosis with beta-interferon 1a]
    V M Rivera
    Dpto de NeurologĂ­a, Baylor College of Medicine, Houston, Texas 77030, USA
    Rev Neurol 31:470-1. 2000
    ..The present study discusses results of an opened prolonged (phase IV) trial at the Baylor/Methodist International Multiple Sclerosis Center using 6 MIU by intramuscular injection once a week...
  6. ncbi Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
    Y C Zang
    Department of Neurology, Baylor College of Medicine, and Baylor Methodist Multiple Sclerosis Center, Houston 77030, USA
    Eur J Immunol 29:1692-700. 1999
    ..The findings are relevant to our understanding of regulation of MBP-reactive T cells in vivo in MS...
  7. ncbi Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis
    Y C Zang
    Multiple Sclerosis Research Laboratory, Department of Neurology, Baylor College of Medicine, Houston 77030, USA
    Eur J Immunol 30:908-13. 2000
    ..The findings have important implications for our understanding of the regulatory mechanism induced by T cell vaccination...
  8. ncbi Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals
    M V Tejada-Simon
    Multiple Sclerosis Research Laboratory, Baylor-Methodist Multiple Sclerosis Center and Department of Neurology, Baylor College of Medicine, Houston, USA
    Eur J Immunol 31:907-17. 2001
    ..The findings have important implications in the understanding of the role of myelin-reactive T cells in MS...
  9. ncbi Urodynamic pattern changes in multiple sclerosis
    S J Ciancio
    Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA
    Urology 57:239-45. 2001
    ..Therefore, urodynamic evaluations should be repeated at regular intervals in symptomatic patients to optimize clinical management, reduce complications, and better enable these patients to manage their neurogenic bladder dysfunction...
  10. ncbi Anti-viral properties of interferon beta treatment in patients with multiple sclerosis
    J Hong
    Department of Neurology and Baylor Methodist Multiple Sclerosis Center, Houston, Texas, USA
    Mult Scler 8:237-42. 2002
    ....
  11. ncbi Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography
    T C Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, TX 75235, USA
    Neurology 61:848-50. 2003
    ..Intermediate dysconjugacy was not detected by 25% of the evaluators. In the most severe cases, INO was not identified by only 6%. Oculographic techniques significantly enhance the precision of INO detection compared to the clinical exam...
  12. ncbi The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    E M Frohman
    University of Texas Southwestern Medical Center at Dallas, USA
    Neurology 61:602-11. 2003
    ..By contrast, normal results on MRI at the time of clinical presentation makes the future development of CDMS considerably less likely...